Content
All Posts > Content under Healthcare
Gilead Sciences Receives Canadian Approval For HIV Drug
Article By:
KKD Healthcare Analytics
Read
Monday, February 20, 2017 3:03 PM EDT
Gilead Sciences Inc. announced that it has received approval in Canada for its Odefsey for treating HIV-1 infection.
OncoSec Medical: Promising Cancer Treatment Overlooked By Market
Article By:
Stone Fox Capital
Read
Monday, February 20, 2017 3:43 AM EDT
OncoSec Medical offers an overlooked biotech with a promising proprietary immunotherapy platform with initial clinical trials showing a combination with anti-PD-1 therapies provides a treatment for melanoma cancer and other devastating cancers.
In this article: ONCS
Biotechnology: Poised To Head Higher
Article By:
Tarun Chandra, CFA
Read
Sunday, February 19, 2017 3:23 AM EDT
Biotechnology sector has struggled to overcome regulatory uncertainty. We believe now there is sufficient momentum for Biotechs to breakout and record new 52-week highs compared to a -21% decline in 2016.
Peace Out
Article By:
Marvin R Clark
Read
Saturday, February 18, 2017 11:07 AM EDT
US stocks have spent the past week setting new record after new record. The S&P 500 and the Nasdaq posted 5 consecutive record high sessions before slipping on Thursday.
Interview With First Choice Healthcare Solutions
Article By:
Trevor Lowenthal
Read
Friday, February 17, 2017 2:52 PM EDT
I had the opportunity to interview Chris Romandetti. the CEO of First Choice Healthcare Solutions. FCHS is a network of non-physician owned medical centers. It is listed on the OTC market and trades at $1.53/share; the stock is worth a closer look.
AstraZeneca Reports Positive Phase 2 Results For Cancer Drug
Article By:
KKD Healthcare Analytics
Read
Friday, February 17, 2017 12:32 PM EDT
The company stock has gained over 5 percent this year so far. Its 12 months performance is a little shaky as the stock lost 3 percent of its value during this time period.
In this article: AZN
Stock Exchange: How To Buy The Dips
Article By:
Jeff Miller
Read
Friday, February 17, 2017 12:28 AM EDT
Pure traders love to buy the dips – and of course sell the rips. Everyone wants to buy low and sell high. Is this part of your strategy? Do you know when and how to make that your plan? Today’s Stock Exchange will help.
Thursday - Commodities, Currency
Article By:
Douglas Gammons
Read
Thursday, February 16, 2017 6:00 PM EDT
The US Dollar looks weak, but not as weak as it was last year. Dollar weakness favors commodities, so I think this means the dollar still favors higher commodity prices and commodity-related stocks, but just not as much as it did last year.
Biotech And Health Care Stock Market Sector Showing Signs Of Life
Article By:
Taki Tsaklanos
Read
Thursday, February 16, 2017 5:43 PM EDT
Biotechnology is now showing the first signs of life. The IBB ETF is up 3 percent on the week.